stars 1 stars 2 stars 3

View Caulis Inc.'s top competitors like BioNet Solutions Pvt Ltd, Cure Data, and DataCure, Inc..

Genomic Health
About Genomic Health Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-based diagnostic tests that help optimize cancer care by addressing the overtreatment of the disease, one of the greatest issues in healthcare today. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic big data into actionable results for treatment planning throughout the cancer patient journey, from diagnosis to treatment selection and monitoring. The Oncotype IQ portfolio of genomic tests and services currently consists of the company's flagship line of Oncotype DX gene expression tests that have been used to guide treatment decisions for more than 750,000 cancer patients worldwide. Genomic Health is expanding its test portfolio to include additional liquid- and tissue-based tests, including the recently launched Oncotype SEQ® Liquid Select™ test. The company is based in Redwood City, California, with international headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth, Facebook, YouTube and LinkedIn. About Oncotype DX® The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions. The company's flagship product, the Oncotype DX Breast Recurrence Score®, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Additionally, the Oncotype DX Breast DCIS Score™ predicts the likelihood of recurrence in a pre-invasive form of breast cancer called DCIS. In prostate cancer, the Oncotype DX Genomic Prostate Score™ predicts disease aggressiveness and further clarifies the current and future risk of the cancer prior to treatment intervention. With more than 750,000 patients tested in more than 90 countries, the Oncotype DX tests have redefined personalized medicine by making genomics a critical part of cancer diagnosis and treatment. To learn more about Oncotype DX tests, visit www.OncotypeIQ.com, www.MyBreastCancerTreatment.org or www.MyProstateCancerTreatment.org.
Redwood City, California, US
Public
$5.8M Revenue
http://www.genomichealth.com
317 Employees
GHDX Ticker
Vital Research
Vital Research was founded in Los Angeles in 1982 by two colleagues who were committed to doing quality social science research that made a difference in the lives of others. In the last thirty-five years, we have grown to serve clients in 30 states and six continents. Our team has the capacity and expertise to craft and implement research, evaluation, and survey projects that can help you answer key questions, generate useful findings, and transform communities. We are committed to inclusive social science research and evaluation, amplifying the voices of marginalized populations and creating vibrant communities. Work with us on education, human services, and workforce development projects toward a world where every person can live their life to its fullest.
Los Angeles, California, US
Private
$17.6M Revenue
http://www.vitalresearch.com
101 Employees
Medizone Germany
We are a pharmaceutical wholesaler based in Munich with an international network of approved partners in the industry! Our focus is the supply of comparator products, analytical samples, unlicensed and emergency medicines. 3 decades of experience in the pharmaceutical industry enable us to provide you with sourcing services at highest quality standards. Our passion is to assist you in the development of new medicines such as biosimilars as well as to help your customers obtaining urgently needed life-saving medications. Cost effective approaches and individual project solutions are our core business on a daily basis. We stand for flexibility, reliability and confidentiality. Medizone – Global Pharma Sourcing Service – Made in Germany Our Services: - Comparator Sourcing for Clinical Trials We source Comparator products from almost anywhere in the World and have direct access to many innovators and approved supply sources. - Analytical Samples for Biosimilar Development We supply analytical samples for Biosimilar development from almost anywhere in the world – Multi-country, Multi-batch and Multi-expiry date approach. - Unlicensed Medicines Supplies We supply prescription only and OTC products to companies that have specialized in unlicensed medicines supplies, government agencies, hospitals and pharmacies. - International Pharma Supplies We supply prescription only and OTC products to authorized wholesalers, licensed importers and aid organisations – from anywhere in the EU with a focus on german products.
Oberhaching, DE
Private
$2M Revenue
http://www.medizone.com
25 Employees
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users